Thus, the patients with OSA in this study who were willing to undergo curative treatment might have been generally health-conscious with early detection of visual change and thereby more likely to achieve favorable visual outcomes after anti-VEGF treatment. The gene discussed is VEGFA; the disease is obstructive sleep apnea syndrome.